Cartesian Therapeutics (RNAC) Change in Account Payables (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Change in Account Payables of $310000.0 for Q1 2026, down 82.96% year-over-year from $1.8 million in Q1 2025, and up 133.23% quarter-over-quarter from -$933000.0 in Q4 2025.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Change in Account Payables (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Change in Account Payables for 12 consecutive years, with $310000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 82.96% year-over-year to $310000.0; the TTM figure through Mar 2026 stood at -$443000.0 (up 6.74% YoY), while the FY2025 annual figure was $1.1 million, up 136.42% from the prior year.
- Change in Account Payables advanced to $310000.0 in Q1 2026 per RNAC's latest filing, from -$933000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q4 2023 and bottomed at -$2.4 million in Q3 2024.
- Historically, Change in Account Payables has averaged $80882.4 across 5 years, with a median of $85000.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Account Payables surged 4050.0% — and 2024, when it tumbled 2923.53%.
- Cartesian Therapeutics' Change in Account Payables stood at $102000.0 in 2022, then jumped by 2643.14% to $2.8 million in 2023, then plunged by 108.47% to -$237000.0 in 2024, then tumbled by 293.67% to -$933000.0 in 2025, then soared by 133.23% to $310000.0 in 2026.
- Business Quant data shows RNAC's Change in Account Payables at $310000.0 in Q1 2026, -$933000.0 in Q4 2025, and $1.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - | -773,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -773,000.00 |
| Mar 31, 2026 | 310,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | 343,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 85,000.00 |
| Jun 30, 2023 | -796,000.00 |
| Mar 31, 2023 | 747,000.00 |
| Dec 31, 2022 | 102,000.00 |
| Sep 30, 2022 | -310,000.00 |
| Jun 30, 2022 | 282,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | 1.44 Mn |